陈尚武

Submitted on 周五, 01/05/2018 - 21:31


性别
男

工作电话
**

电子邮件
lsschshw@mail.sysu.edu.cn

职称
教授

导师类型
博士生导师

学历
博士研究生

学科方向
0710生物学-10生物化学与分子生物学


讲授课程
生物化学

承担课题
在研项目：
天然免疫与适应性免疫应答的协作与交替演化，“973”项目子课题，2015.01-2017.8
先天免疫抗病毒新机制的发现与比较研究，广州市科技计划重点项目，2016.01-2018.12
（宫颈）癌前病变的Warburg-like effect与糖代谢重编程机制研究，国家自然科学基金面上项目，2017.01-2020.12


论文专著
Yu L*, Chen X, Sun X, Wang L, Chen S*. The Glycolytic Switch in Tumors: How Many Players Are Involved? J Cancer. 2017 Sep 20;8(17):3430-3440.
Sun X, Liu X, Xia M, Yang S, Fei L, Zhang M, Ma H, Wang L, Chen S*, Yu L*.The combined application of urinary liquid-based cytology with fluorescence in situ hybridization and p16/Ki-67 dual immunostaining is valuable for improving the early diagnosis of upper tract urothelial carcinomas. Diagn Cytopathol. 2017 Oct;45(10):895-902.
Yu L*, Chen X, Wang L, Chen S*. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget. 2016 Jun;7(25):38908-38926.
Ma H, Tian T, Liang S, Liu X, Shen H, Xia M, Liu X, Zhang W, Wang L, Chen S*, Yu L*. Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer. Oncotarget. 2016 Mar;7(9):10594-605.
Duan C, Liu X, Liang S, Yang Z, Xia M, Wang L, Chen S*, Yu L*.Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma. J Cell Mol Med. 2014 May;18(5):863-74.
Liang S, Tian T, Liu X , Shi H, Tang C, Yang S, Wang L, Chen S , Yu L*. Microarray analysis revealed markedly differential miRNA expression profiles in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. Future Oncol. 2014 Oct;10(13):2023-32.
Yu L*, Duan C, He M, Yang Z, Chen G,? Shi H,? Yang S, Wang L, Chen S*. Diagnostic Value of HMGB1Immunostaining on Cell Blocks From Residual Liquid-Based Gynecologic Cytology Specimens. Diagn Cytopathol. 2014 Sep;42(9):802-8.
Yu L*, Wang L, Chen S*. Dual character of Toll-like receptor signaling: Pro-tumorigenic effects and anti-tumor functions. Biochim Biophys Acta. 2013 Apr;1835(2):144-154.
Yu L*, Wang L, Chen S. Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis? Cell Mol Life Sci. 2012 Mar;69(6):935-49
Yu L*, He M, Yang Z, Chen G, Li M, Wang L, Chen S*. Olfactomedin 4 Is a Marker for Progression of Cervical Neoplasia. Int J Gynecol Cancer. 2011 Feb;21(2):367-372.
Yu L, Wang L, Chen S. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers. Neoplasma. 2011 Jan;58(1):9-11.
Yu L*, Wang L, Chen S*. Endogenous Toll-like receptor ligands and their biological significance. J Cell Mol Med. 2010 Nov;14(11):2592-603.
Yu L*, Wang L, Li M, Zhong J, Wang Z, Chen S*. Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia. Cancer Immunol Immunother. 2010 Jul;59(7):1021-8.
Yu L*, Wang L, Zhong J, Chen S*. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus l1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens. Cancer Cytopathol. 2010 Feb;118(1):47-55.
Yu L*, Wang L, Chen S*. Toll-like receptors, inflammation and tumor in the human female reproductive tract. Am J Reprod Immunol. 2009 Jul;62(1):1-8.
Yu L，Chen S*. Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother. 2008 Sep;57(9):1271-8.
?
?